Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. (ESPR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ESPR · as of Jun 9, 2026
Key Statistics
Explore Esperion Therapeutics, Inc. Data
espr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 25 · Buy rate: 32.0%
The ESPR analyst consensus is Hold, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month price target is $3.19, representing +1.27% upside from the current price of $3.15.
Competitors & Peers
espr competitorsESPR
ABSI
AQST
CRVS
EBS
OFIXStock Performance
Full HistoryAbout Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. operates as a pharmaceutical firm, concentrating on the development and commercialization of treatments for individuals with high levels of low-density lipoprotein (LDL) ch…
what is esperion therapeutics, inc. · espr stock overview · esperion therapeutics, inc. company profile · who is esperion therapeutics, inc. ceo · espr NASDAQ · esperion therapeutics, inc. headquarters · esperion therapeutics, inc. business segments
About Stock Overview & Key Data
Esperion Therapeutics, Inc. (ESPR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 26, 2013. As of the latest trading session, ESPR stock price is $3.15, with a market capitalization of $654.9M. The stock has returned +162.50% over the past 12 months and -14.86% year-to-date.
According to 25 Wall Street analysts, the consensus rating for Esperion Therapeutics, Inc. stock is Hold, with an average 12-month price target of $3.19. In fiscal year 2025, Esperion Therapeutics, Inc. reported revenue of $403.1M and net income of -$22.7M. For detailed data — including Esperion Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Esperion Therapeutics, Inc. (ESPR) stock price is $3.15. The stock is traded on NASDAQ under the ticker symbol ESPR. The 52-week range is $0.95 – $4.18.